XML 40 R25.htm IDEA: XBRL DOCUMENT v3.24.4
ASSET PURCHASE AGREEMENT (Tables)
12 Months Ended
Sep. 30, 2024
ASSET PURCHASE AGREEMENT  
Schedule of consideration paid for asset acquisition

Cash

    

$

625,000

37,500 Company shares at $25.40/share (share price on July 12, 2023)

 

952,500

Direct transaction costs

 

437,360

Total consideration paid for acquiring Spindle RNAP enzyme platform

$

2,014,860